Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Children put at risk as vaccinations hit 10-year low

Children at risk as vaccinations hit

Last year there were 2,911 confirmed measles cases in England

Pic credit: iStock

The UK is at risk of potentially deadly diseases amongst children after vaccination levels dropped to its lowest in ten years.

Britain remains below the 95 per cent coverage threshold recommended by the World Health Organisation (WHO) for all routine vaccines by the age of five.


Before the age of five, children are supposed to have the MMR jab; the six-in-one vaccine against diphtheria, tetanus, whooping cough (pertussis), polio, Haemophilus influenzae type b and hepatitis B; and the pneumococcal conjugate vaccine.

Children also get vaccines against meningitis B and C. Missed vaccines can be caught up with at any age.

However, a rise in vaccine scepticism has led to a significant drop in numbers.

Vaccination rates for the six-in-one jab plunged from 89 per cent in 2014 to 83 per cent in 2024 for children, according to an analysis by The Sunday Times.

Rates have dropped from 88 per cent to 84 per cent for MMR.

Last year there were 2,911 confirmed measles cases in England, the highest number since 2012, with outbreaks in Birmingham and London. There were 14,894 confirmed cases of whooping cough in 2024 and 11 babies died.

Dr Julie Yates, the UK Health Security Agency’s deputy director for immunisation, told The Sunday Times: “The decline of the uptake of routine childhood vaccinations over the past decade, including MMR and flu, means that many thousands of children are left unprotected with the risk of outbreaks linked to nurseries and schools.

“Taking vaccination into homes, for a small number of families who have additional needs or who are not able to access core GP services, is another important step towards addressing the decline and ensuring children in areas with the lowest vaccination uptake and potentially greatest need are also protected by supporting parents and offering them greater flexibility.”

Earlier this year, the Pharmacy Vaccinations Development Group (PVDG), a coalition of organisations representing the entire vaccines supply chain, has urged the government to leverage community pharmacies in addressing declining vaccination rates.

The group recommended expanding the NHS National Booking Service to include all vaccines, integrating it with pharmacy booking systems to provide a one-stop-shop for patients.

The government has asked local NHS regions to draw up plans to improve vaccine uptake in their area by this winter.

Last week, NHS England a flu vaccination walk-in finder service will launch in October that will help patients easily look up where they can walk into a community pharmacy to have a vaccine.

The announcement was part of the NHS urgent and emergency care plan 2025/26 which is also looking at how to ‘strengthen the childhood vaccination offer’.

“Each year we send out millions of letters, texts and emails to parents and carers to encourage them to book their child’s recommended vaccination appointments — but we recognise some of the challenges busy parents may face, and improving access to vaccines is a key part of our vaccination strategy,” Dr Amanda Doyle, national director for primary care at NHS England, told the Sunday Times.

“We want to make sure as many children as possible are protected against becoming seriously unwell and our new trialling of home visits aims to reach those who haven’t previously come forward for their jabs — helping to protect children, and their friends and families.”

More For You

Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less
Pharma industry group unhappy with NHS drug pricing offer

The ABPI warned that £2 billion of potential investment could be under risk

Pic credit: istock

Pharma industry group unhappy with NHS drug pricing offer

The Association of the British Pharmaceutical Industry (ABPI) has rejected the UK government’s offer to cut the cost of NHS drugs pricing scheme as it felt it was inadequate.

The industry group warned that £2 billion of potential investment could be under risk and wanted prime minister Keir Starmer to intervene, The Times reports.

Keep ReadingShow less
Day Lewis celebrates 50 years of delivering care to communities

The Patel family at the unveiling of the commemorative plaque ceremony

Day Lewis celebrates 50 years of delivering care to communities

Day Lewis honoured "the people, purpose and partnerships" as it celebrated 50 years of service by unveiling a commemorative plaque at the company’s support office in Croydon.

As one of the UK’s largest independent pharmacy chains, Day Lewis has delivered trusted care to communities across the country since it was founded in 1975, by brothers Kirit and JC Patel, who was on hand to unveil the plaque.

Keep ReadingShow less
CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

CPE said the committee’s discussions are fully shaped by pharmacy owners’ views and experiences

Pic credit: iStock

Pharmacy owners asked to share views on new contract and its financial implications

Pharmacy owners can share their thoughts on service developments and their financial security before the upcoming Community Pharmacy England (CPE) committee meeting to be held on June 25 and 26.

The new Community Pharmacy Contractual Framework (CPCF) was completed in March with the various service and regulatory changes still in progress.

Keep ReadingShow less
Cancer treatment impact

There have been supply issues with Creon since the summer of 2024

Pic credit: iStock

Cancer patients struggle amid digestive drug shortage

Pharmacists in the Channel Islands have revealed that there is a shortage of a drug used to support digestion in cancer patients.

Creon is a pancreatic enzyme replacement therapy (PERT), which helps people living with conditions such as cystic fibrosis, pancreatitis, and pancreatic cancer to digest food.

Keep ReadingShow less